Anti-GRM7 antibody
Specifications
| Product Cat#: | AB-06-2045 |
| Product type: | Primary antibody |
| Antigen: | GRM7 |
| Immunogen: | Purified recombinant fragment of human GRM7 expressed in E. Coli. |
| Species immunized: | Mouse |
| Isotype: | IgG1 |
| Applications: | Western Blot (1:500-1:2000); Flow Cytometry (1:50-1:100); Immunocytochemistry (1:50-1:200) |
| Reactivity: | Human |
| Clonality (clone number): | Monoclonal (D3-G8) |
| Form: | Liquid |
| Buffer: | 1*TBS (pH7.4), 1%BSA, 40%Glycerol. Preservative: 0.05% Sodium Azide. |
| Concentration: | 1 mg/ml |
| Purity: | Protein A affinity purified |
| Storage: | Aliquot and freeze at -20℃. Avoid multiple freeze/thaw cycles. |
| Alternative names: | FLJ40498 antibody |
| GLUR7 antibody | |
| Glutamate receptor metabotropic 7 antibody | |
| GPRC1G antibody | |
| GRM7 antibody | |
| GRM7_HUMAN antibody | |
| Metabotropic glutamate receptor 7 antibody | |
| MGLU7 antibody | |
| mGluR7 antibody | |
| OTTHUMP00000206961 antibody | |
| OTTHUMP00000214674 antibody | |
| OTTHUMP00000214675 antibody |
Show More
Target information
G-protein coupled receptor for glutamate. Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors, such as adenylate cyclase. Signaling inhibits adenylate cyclase activity.
Provider
Erpantech Laboratory